New Alzheimer’s drug slows cognitive decline by 35%, trial results show

New Alzheimer’s drug slows cognitive decline by 35%, trial results show

A new Alzheimers drug slowed cognitive decline by 35%, according to late-stage trial results, raising the prospect of a second effective treatment for the disease. Donanemab met all goals of the tri… [+3408 chars]

Read More
Top